Capsule Endoscopy Market By Product Type (Small Bowel Capsule Endoscopy, Colon Capsule Endoscopy, Esophageal Capsule Endoscopy); By Application (Obscure Gastrointestinal Bleeding, Crohn’s Disease Diagnosis, Tumor Detection); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The capsule endoscopy market is valued at around $870 million and is expected to grow to $1.56 billion by 2030, with an estimated annual growth rate of 10.3%. This growth is largely driven by the increasing number of gastrointestinal (GI) diseases and the growing preference for less invasive diagnostic methods.

 

Capsule endoscopy is an innovative tool in managing GI practice. This device takes pictures within the body using small ball-like devices called endoscopes. This noninvasive procedure has replaced conventional invasive techniques for diagnosing disorders such as small bowel bleeding, Crohn’s disease, celiac disease, and tumors. It is also becoming the method of choice because it is comfortable, efficient, and can access areas in the GI tract that other techniques cannot.

 

Market Dynamics

Global GI Health Crisis: How Capsule Endoscopy is Closing the Diagnostic Gap

Rising Prevalence of Gastrointestinal (GI) Disorders: The increasing incidence of GI diseases such as Crohn’s disease, colorectal cancer, and gastrointestinal bleeding drives demand for minimally invasive diagnostic procedures like capsule endoscopy. According to the World Cancer Research Fund, colorectal cancer is the third most common cancer globally, with nearly 1.9 million new cases in 2022. Capsule endoscopy is widely used for detecting small bowel bleeding and tumors, offering a less invasive alternative to traditional endoscopy.

Technological Advancements in Capsule Endoscopy: Continuous innovations, such as AI-assisted image processing, wireless communication, and improved battery life, are enhancing the diagnostic accuracy and efficiency of capsule endoscopy. The adoption of AI-based capsule endoscopy is expected to grow at a CAGR of 10.5% from 2024 to 2030, improving real-time diagnosis. Medtronic’s PillCam Genius™ uses AI technology to automate video analysis, reducing the time required for clinicians to review images.

 

Capsule Endoscopy Market Expansion: Opportunities in Emerging Economies

Growing Adoption in Emerging Markets: Developing regions, including Asia-Pacific and Latin America, present untapped potential due to increasing healthcare investments, rising disposable incomes, and improved medical infrastructure. The Asia-Pacific capsule endoscopy market is projected to expand at a CAGR of 22.1% from 2024 - 2030 due to rising healthcare expenditures. Countries like India and China are witnessing higher adoption rates of capsule endoscopy due to government healthcare initiatives and an increasing burden of GI diseases.

Expansion of AI and Machine Learning Integration: AI-powered capsule endoscopy solutions improve diagnostic accuracy, reduce physician workload, and enhance the efficiency of image analysis. AI-assisted endoscopy solutions have shown an accuracy rate of over 90% in detecting abnormalities compared to traditional manual review. Olympus Corporation has been investing in AI-powered diagnostic solutions to support gastroenterologists in real-time decision-making.

 

Capsule Endoscopy Market Challenges: Barriers to Global Adoption

High Cost of Capsule Endoscopy Procedures: The high cost of capsule endoscopy, including the price of disposable capsules & the need for specialized software, limits adoption in cost-sensitive regions. The average cost of a capsule endoscopy procedure ranges from $500 to $2,000, making it less accessible in low-income countries. Limited reimbursement policies in certain regions hinder the widespread adoption of capsule endoscopy technologies.

Limited Battery Life and Data Transmission Challenges: Capsule endoscopy relies on battery-operated devices with limited recording time, posing challenges for capturing comprehensive GI tract images. Most capsule endoscopy devices have a battery life of 8-12 hours, which may not be sufficient for full GI tract evaluation in some cases. IntroMedic’s MiroCam® has introduced advanced wireless data transmission technology to improve image capture efficiency, but challenges remain in long-duration diagnostics.

 

Capsule Endoscopy Market Segmentation: Tailoring Solutions for Precision Growth

By Product Type:

• Small Bowel Capsule Endoscopy

• Colon Capsule Endoscopy

• Esophageal Capsule Endoscopy

 

By Application:

• Obscure Gastrointestinal Bleeding

• Crohn’s Disease Diagnosis

• Tumor Detection

 

By Region:

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Segment Analysis of Capsule Endoscopy Market

By Product Type:

Leading Segment: Small Bowel Capsule Endoscopy (SBCE)

Small Bowel Capsule Endoscopy (SBCE) is expected to continue holding the largest share of the capsule endoscopy market, contributing more than 60% of the market revenue by 2025. The segment's growth is driven by the growing prevalence of small bowel disorders such as Crohn's disease and obscure gastrointestinal bleeding, as well as the growing demand for non-invasive diagnostic methods. SBCE is considered the gold standard for diagnosing small bowel conditions, particularly those difficult to reach with traditional endoscopic procedures. Companies like Medtronic and Olympus dominate the small bowel capsule endoscopy market, with their innovative offerings, such as Medtronic's PillCam SB3, offering advanced features such as higher resolution imaging and extended battery life.

Fastest-Growing Segment: Colon Capsule Endoscopy

Colon Capsule Endoscopy (CCE) is growing at a rate of approximately 15-20% annually, making it the fastest-growing segment in the capsule endoscopy market. The increase in colorectal cancer cases, particularly in aging populations, combined with the rising demand for non-invasive diagnostic tools, is driving growth. CCE offers a less invasive, more comfortable alternative to traditional colonoscopy procedures, which makes it a popular choice among patients & healthcare providers. In 2020, the European Society of Gastrointestinal Endoscopy (ESGE) provided a framework for the use of CCE, further promoting its adoption in clinical settings.

 

By Application:

Leading Segment: Obscure Gastrointestinal Bleeding

Obscure Gastrointestinal Bleeding (OGIB) remains the leading application for capsule endoscopy, representing around 40-50% of the overall market. The increasing incidence of GI bleeding, particularly in the small intestine, has made capsule endoscopy the diagnostic method of choice. As many cases of GI bleeding go undiagnosed with traditional methods, capsule endoscopy has gained significant traction in clinical settings due to its ability to accurately locate the source of bleeding. Capsule endoscopy has revolutionized the diagnosis of obscure GI bleeding, allowing for precise identification of lesions, vascular malformations & tumors in the small intestine, an area inaccessible to conventional endoscopy.

Fastest-Growing Segment: Tumor Detection

The tumor detection segment is expanding rapidly, with a projected annual growth rate of 18-22%. This is being fueled by the increasing awareness and incidence of small intestine tumors, such as carcinoid tumors and adenocarcinomas. Advances in capsule technology, including better imaging resolution and the ability to provide more detailed views of the digestive tract, have enabled the detection of small tumors in areas previously difficult to examine. The adoption of capsule endoscopy for tumor detection is expected to increase significantly due to the growing shift toward non-invasive diagnostic procedures for early cancer detection.

 

By Region:

Leading Region: North America

North America holds the largest market share, accounting for approximately 45-50% of the global capsule endoscopy market. The high prevalence of gastrointestinal diseases in the U.S., combined with strong healthcare infrastructure, government initiatives promoting early disease detection & a higher adoption rate of advanced medical technologies, has contributed to North America's market dominance. Major companies such as Medtronic & Olympus, alongside the increasing use of capsule endoscopy in both public and private healthcare settings, have reinforced North America's leadership in the market.

Fastest-Growing Region: Asia-Pacific

The Asia-Pacific region is expected to grow at the fastest pace, with a projected CAGR of 20-25% over the next 5-7 years. Countries such as China, India & Japan are seeing rapid improvements in healthcare infrastructure, increased awareness of gastrointestinal diseases, and a rising focus on non-invasive diagnostic technologies. The demand for capsule endoscopy in countries like India is rising, driven by the increasing prevalence of gastrointestinal diseases and growing healthcare access in rural areas. The market is expanding with the support of international companies entering the region and local collaborations to increase availability and affordability of capsule endoscopy devices.

 

Key Strategies

• Product Innovation: Leading companies are heavily investing in next-generation capsule endoscopy devices with enhanced imaging, artificial intelligence (AI) integration, and extended battery life to improve diagnostic capabilities and accuracy. Advanced innovations are driving higher adoption rates among healthcare providers. Olympus’ EndoCapsule EC-10 provides high-resolution images and a 3D track visualization system, allowing clinicians to better locate abnormalities within the small intestine. By continuously enhancing imaging quality, battery efficiency & AI-powered diagnostics, companies are improving detection rates of GI disorders such as Crohn’s disease and small bowel tumors, leading to higher adoption rates in hospitals and clinics.

• Partnerships and Collaborations: CapsoVision, a U.S.-based company, collaborates with major hospitals & gastroenterology clinics to introduce its CapsoCam Plus, which features a 360-degree panoramic view of the GI tract. By working closely with healthcare providers, the company trains clinicians, supports clinical trials & ensures seamless technology adoption. Partnerships with hospitals and healthcare providers enable faster clinical acceptance, wider accessibility & improved diagnostic accuracy, ultimately driving higher adoption rates and market growth.

• Geographic Expansion: Jinshan Science & Technology, a leading Chinese manufacturer of capsule endoscopy solutions, is aggressively expanding its footprint in India, Southeast Asia & the Middle East. The company is leveraging lower-cost manufacturing, government healthcare initiatives & rising demand for non-invasive diagnostic tools to establish a stronger presence. By entering high-growth regions with large patient populations, companies can increase sales volume, improve market presence, & drive long-term revenue growth while catering to the unmet medical needs in these regions.

 

Capsule Endoscopy Market Leaders: Innovating the Future of GI Care

Major Companies in the Capsule Endoscopy Market:

• Medtronic

• Olympus Corporation

• IntroMedic Co., Ltd.

• Jinshan Science & Technology

• CapsoVision, Inc.

• Check-Cap Ltd.

• RF System Lab

• AnX Robotica

• AccuRead Endoscopy Inc.

• Dr. Falk Pharma GmbH

 

Capsule Endoscopy Market Report Coverage

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 1.1 Billion
Revenue Forecast in 2030	USD 1.56 Billion
Overall Growth Rate	CAGR of 10.3%
Base Year for Estimation	2022
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Product Type, By Application, By Region
By Product Type	Small Bowel Capsule Endoscopy, Colon Capsule Endoscopy, Esophageal Capsule Endoscopy
By Application	Obscure Gastrointestinal Bleeding, Crohn’s Disease Diagnosis, Tumor Detection
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, UK, Germany, France, China, Japan, India, etc.
Pricing and Purchase Options	Customized options available

 

Key Strategies:

• Product Innovation: Medtronic’s PillCam™ SB3 and Olympus' EndoCapsule EC-10 lead the market due to advanced imaging and AI features.

• Partnerships and Collaborations: Companies like CapsoVision collaborate with hospitals to promote product adoption.

• Geographic Expansion: Jinshan Science & Technology focuses on expanding its footprint in emerging markets like India and Southeast Asia.

 

Future Outlook

The capsule endoscopy market is bound to have promising growth, fostered by enhancements in imaging techniques, the incorporation of artificial intelligence, and the rising preference of patients to diagnose gastrointestinal diseases in the initial stage. Ongoing emerging trends include the designing of robotic capsule endoscopy which will have an enhanced ability to locate and deliver treatment to specific points in the human digestive system. Moreover, wireless data transfer and application based diagnostic clouds are expected to improve the efficiency and decrease the cost. New market entrants and start-ups bringing AI and robotics know-how into the market may further open growth opportunities and enhance patient outcomes.